N–Acyl–3,5–bis(arylidene)-4-piperidones and related compounds which stimulate fyn kinase

References

• Dimmock JR, Sidhu KK, Chen M, Reid RS, Allen TM, Kao GY, Truitt GA. Evaluation of some Mannich bases of cycloalkanones and related compounds for cytotoxic activity. Eur J Med Chem 1993; 28: 313–322
   Web of Science ®Google Scholar
• Dimmock JR, Kandepu NM, Nazarali AJ, Motaganahalli NL, Kowalchuk TP, Pugazhenthi U, Prisciak JS, Quail JW, Allen TM, LeClerc R, Santos CL, De Clercq E, Balzarini J. Sequential cytotoxicity: A theory evaluated using novel 2-[4-(3-aryl-2-propenoyloxy)phenylmethylene]cyclohexanones and related compounds. J Med Chem 2000; 43: 3933–3940
   PubMed Web of Science ®Google Scholar
• Remers WA. Antineoplastic agents. Wilson and Gisvold's textbook of organic medicinal and pharmaceutical chemistry10th ed., JN Delgado, WA Remers. Lippincott-Raven, Philadelphia 1998; 353
   Google Scholar
• Aronov AM, Murcko MA. Toward a pharmacophore for kinase frequent hitters. J Med Chem 2004; 47: 5616–5619
   PubMedGoogle Scholar
• Clark DD, Peterson BR. Analysis of protein tyrosine kinase inhibitors in recombinant yeast lacking the ERG6 gene. Chem Bio Chem 2003; 4: 101–107
   Google Scholar
• Levitzki A, Gazit A. Tyrosine kinase inhibition: An approach to drug development. Science 1995; 267: 1782–1788
   PubMed Web of Science ®Google Scholar
• Dimmock JR, Chamankah M, Das U, Zello GA, Quail JW, Yang J, Nienaber KH, Sharma RK, Selvakumar P, Balzarini J, De Clercq E, Stables JP. Cytotoxic and topographical properties of 6-arylidene-2-dimethylaminomethylcyclohexanone hydrochlorides and related compounds. J Enz Inhib Med Chem 2004; 19: 1–10
   PubMed Web of Science ®Google Scholar
• Dimmock JR, Patil SA, Shyam K. Evaluation of some Mannich bases of 1-aryl-1-ethanones and related ketones for anticonvulsant activities. Pharmazie 1991; 46: 538–539
   PubMedGoogle Scholar
• Dimmock JR, Taylor WG. Evaluation of nuclear-substituted styryl ketones and related compounds for antitumor and cytotoxic properties. J Pharm Sci 1975; 64: 241–249
   Google Scholar
• Dimmock JR, Jha A, Zello GA, Sharma RK, Shrivastav A, Selvakumar P, Allen TM, Santos CL, Balzarini J, De Clercq E, Manavathu EK, Stables JP. 3,5-Bis(phenylmethylene)-1-(N-arylmaleamoyl)-4-piperidones: A novel group of cytotoxic agents. J Enz Inhib Med Chem 2003; 18: 325–332
   PubMed Web of Science ®Google Scholar
• Dimmock JR, Jha A, Zello GA, Quail JW, Oloo EO, Nienaber KH, Kowalczyk ES, Allen TM, Santos CL, De Clercq E, Balzarini J, Manavathu EK, Stables JP. Cytotoxic N-[4-(3-aryl-3-oxo-1-propenyl)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidones and related compounds. Eur J Med Chem 2002; 37: 961–972
   PubMed Web of Science ®Google Scholar
• Dimmock JR, Padmanilayam MP, Puthucode RN, Nazarali AJ, Motaganahalli NL, Zello GA, Quail JW, Oloo EO, Kraatz H-B, Prisciak JS, Allen TM, Santos CL, Balzarini J, De Clercq E, Manavathu EK. A conformational and structure-activity relationship study of cytotoxic 3,5-bis-arylidene-4-piperidones and related N-acryloyl analogues. J Med Chem 2001; 44: 586–593
   PubMed Web of Science ®Google Scholar
• Jones CD, Jevnikar AJ, Pike AJ, Peters MK, Black LJ, Thompson AR, Falcone JF, Clemens JA. Antiestrogens.2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b] thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b] thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity. J Med Chem 1984; 27: 1057–1066
   PubMed Web of Science ®Google Scholar
• Bhanderi V, Kim KL, Pallen CJ. Physical and functional interactions between receptor-like protein-tyrosine phosphatase and p59fyn. J Biol Chem 1998; 273: 8691–8698
   PubMedGoogle Scholar
• Cheng HC, Nishio H, Hatase O, Ralph S, Wang JH. A synthetic peptide derived from p34cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J Biol Chem 1992; 267: 9248–9256
   PubMedGoogle Scholar
• Sharma RK. Assay and purification of calmodulin-dependent protein kinase. Calcium signaling protocols: Methods in molecular biology, DG Lambert. Humana Press, Totowa, New Jersey 2006; Vol 312: 305–324
   Google Scholar
• Haas TA, Plow EF. Development of a structural model for the cytoplasmic domain of an integrin. Protein Eng 1997; 10: 1395–1405
   PubMedGoogle Scholar
• Dimmock JR, Kumar P, Nazarali AJ, Motaganahalli NL, Kowalchuk TP, Beazely MA, Quail JW, Oloo EO, Allen TM, Szydlowski J, De Clercq E, Balzarini J. Cytotoxic 2,6-bis(arylidene)cyclohexanones and related compounds. Eur J Med Chem 2000; 35: 967–977
   PubMed Web of Science ®Google Scholar
• Arold ST, Ulmer TS, Mulhern TD, Werner JM, Ladbury JE, Campbell ID, Noble ME. The role of src homology 3-Src homology 2 interface in the regulation of Src kinases. J Biol Chem 2001; 276: 17199–17205
   PubMed Web of Science ®Google Scholar
• Xu W, Harrison SC, Eck MJ. Three-dimensional structure of the tyrosine kinase 6-Src. Nature 1997; 385: 595–602
   PubMed Web of Science ®Google Scholar